Last edition
News about "pharma growth"
OneSource Reports INR 47 Crore Net Loss in Q3 FY26 as Revenue Falls 26 Percent
OneSource Specialty Pharma reported a weak performance in the third quarter of FY26, posting a net loss of INR 47 crore for the quarter ended December 31, 2025. The company’s revenue declined 26 percent year on year to INR 290 crore, largely due to delays in converting a key service agreement into a commercial supply contract.
Pharma Growth | 27/01/2026 | By Darshana | 180
JB Chemicals Delivers Strong Q3 FY26 Results with Double-Digit Growth
JB Chemicals and Pharmaceuticals Ltd (JB Pharma) reported a strong financial performance for the third quarter of FY26, with consolidated revenue rising to INR 1,065 crore, an increase of around 11 percent compared to the same quarter last year.
Pharma Growth | 20/01/2026 | By Darshana | 195
Bayer Targets Return to Mid-Single-Digit Pharma Growth by 2027
Addressing investors at a major healthcare conference, Stefan Oelrich, head of Bayer’s pharmaceuticals business, said the company expects 2026 to be the final year significantly affected by the loss of exclusivity on its blockbuster anticoagulant Xarelto. From 2027 onward, Bayer anticipates a recovery driven by newer medicines and pipeline progress.
Pharma Growth | 14/01/2026 | By Darshana | 553
Syntegon Posts Strong Q3 Performance with Accelerating Pharma Growth and Higher Profit Margins
Syntegon recorded double-digit growth in sales and profitability, supported by strong pharma demand, new technology launches, and continued operational improvements.
Pharma Growth | 24/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy